Synonym/Acronym
Cu.
Rationale
To evaluate and monitor for copper deficiency (e.g., Menkes disease/syndrome) or elevated copper levels (e.g., Wilson disease).
Patient Preparation
There are no food, fluid, activity, or medication restrictions unless by medical direction.
Normal Findings
Method: Inductively coupled plasma-mass spectrometry.
Age | Conventional Units | SI Units (Conventional Units × 0.157) |
---|
Newborn | 946 mcg/dL | 1.47.2 micromol/L | Child | 60150 mcg/dL | 9.423.6 micromol/L | 1519 yr | 80171 mcg/dL | 12.626.8 micromol/L | Adult | | | Male | 71141 mcg/dL | 11.122.1 micromol/L | Female | 80155 mcg/dL | 12.624.3 micromol/L | Pregnant female | 118302 mcg/dL | 18.547.4 micromol/L |
Values increase in older adults. |
Study type: Blood collected in a royal bluetop, trace elementfree tube; related body system: Circulatory/Hematopoietic and Digestive systems.
Copper is an important cofactor for the enzymes that participate in the formation of hemoglobin, melanin, and collagen. Copper is also a component of coagulation factor V and assists in the oxidation of glucose. It is required for melanin pigment formation and maintenance of myelin sheaths and is used to synthesize ceruloplasmin. Copper levels vary with intake. Levels vary diurnally and peak during morning hours. This mineral is absorbed in the stomach and duodenum, stored in the liver, and excreted in urine and in feces with bile salts. Copper deficiency results in neutropenia and a hypochromic, microcytic anemia that is not responsive to iron therapy. Other signs and symptoms of copper deficiency include osteoporosis, depigmentation of skin and hair, impaired immune system response, and possible neurological and cardiac abnormalities.
Knowledge of genetics assists in identifying those who may benefit from additional education, risk assessment, and counseling. Genetics is the study and identification of genes, genetic mutations, and inheritance. For example, genetics provides some insight into the likelihood of inheriting a medical condition such as Menkes disease (syndrome) or Wilson disease. Some conditions are the result of mutations involving a single gene, whereas other conditions may involve multiple genes and/or multiple chromosomes. Menkes disease is an example of a recessive sex-linked genetic disorder passed on from a mother to male children; approximately 30% of cases result from new mutations in the affected gene, which means those patients will not have a family history of the disease. Wilson disease is an example of an autosomal recessive disorder in which the offspring inherits a copy of the defective gene from each parent. Further information regarding inheritance of genes can be found in the study titled Genetic Testing.
Factors That May Alter the Results of the Study
- Drugs and other substances that may increase copper levels include anticonvulsants and oral contraceptives.
- Drugs and other substances that may decrease copper levels include citrates, penicillamine, and valproic acid.
Other Considerations
- Excessive therapeutic intake of zinc may interfere with intestinal absorption of copper.
Increased In
Ceruloplasmin is an acute-phase reactant protein and the main protein binder of copper; therefore, copper levels will be increased in many inflammatory conditions, including cancer. Estrogens increase levels of binding protein; therefore, copper is elevated in pregnancy and estrogen therapy.
- Anemias(related to increased red blood cell [RBC] production)
- Ankylosing rheumatoid spondylitis
- Biliary cholangitis(related to release from damaged liver tissue)
- Collagen diseases
- Complications of hemodialysis (trace element disturbances related to contamination from dialysate fluid and the disease process itself can be significant and can compound over time)
- Hodgkin disease
- Infections
- Inflammation
- Leukemia
- Malignant tumors
- Myocardial infarction (MI) (a correlation exists among copper levels, and creatine kinase in MI; the pathophysiology is unclear, but some studies indicate a relationship between trace metal levels and risk of acute MI)
- Pellagra(related to niacin deficiency; niacin is an essential cofactor in reactions involving copper)
- Poisoning from copper-contaminated solutions or insecticides containing copper sulfate (related to excessive accumulation due to environmental exposure)
- Pregnancy
- Pulmonary tuberculosis
- Rheumatic fever
- Rheumatoid arthritis
- Systemic lupus erythematosus
- Thalassemias(related to zinc deficiency of thalassemia and increased rate of release from hemolyzed RBCs; copper and zinc compete for the same binding sites so that a deficiency in one results in an increase of the other)
- Thyroid disease (hypothyroid or hyperthyroid) (related to stimulation of thyroid hormone production by copper)
- Trauma
- Typhoid fever
- Use of copper intrauterine device (related to copper leaching from the device)
Decreased In
- Burns(related to loss of stores in tissue and possibly to competitive inhibition of zinc-containing medications or vitamins administered as part of burn therapy)
- Cystic fibrosis (related to inadequate intake and absorption)
- Dysproteinemia(related to decreased transport to and from stores)
- Infants (related to inadequate intake of milk or consumption of milk deficient in copper; especially premature infants)
- Iron-deficiency anemias (some) (related to decreased absorption of iron from the intestines and transfer from tissues to plasma; iron is essential to hemoglobin formation)
- Long-term total parenteral nutrition(related to inadequate intake)
- Malabsorption disorders (celiac disease, tropical sprue) (related to inadequate absorption)
- Malnutrition(related to inadequate intake)
- Menkes disease/syndrome (evidenced by a severe genetic X-linked defect causing failed transport to the liver and tissues)
- Nephrotic syndrome(related to loss of transport proteins)
- Occipital horn syndrome(evidenced by an inherited disorder of copper metabolism; similar to Menkes disease)
- Wilson disease (evidenced by a genetic defect causing failed transport to the liver and tissues)
Before the Study: Planning and Implementation
Teaching the Patient What to Expect
- Discuss how this test can assist in monitoring the amount of copper in the body.
- Explain that a blood sample is needed for the test.
- Future samples may be needed to trend copper levels and provide accurate therapeutic interventions.
After the Study: Implementation & Evaluation Potential Nursing Actions
Treatment Considerations
- Discuss symptoms of copper deficiency, which include tingling with sensation loss in the hands and feet, fatigue, anemia, weakness, confusion, depression, poor coordination, irritability, cold sensitivity, pale skin, vision loss.
- Facilitate treatment for copper deficiency: causal identification and supplement administration.
- Encourage eating foods that are good sources of copper.
Nutritional Considerations
- Those with increased copper levels should avoid foods rich in copper and increase intake of elements (zinc, iron, calcium, and manganese) that interfere with copper absorption.
- Copper deficiency does not normally occur in adults, but patients receiving long-term total parenteral nutrition should be evaluated if signs and symptoms of copper deficiency appear.
- Explain that organ meats, shellfish, nuts, and legumes are good sources of dietary copper.
Clinical Judgement
- Consider how to overcome the lack of understanding regarding the role of copper in overall health.
Follow-Up and Desired Outcomes
- Acknowledges contact information provided for the U.S. Department of Agricultures resource for nutrition (www.choosemyplate.gov).